350153-134x178.jpg

Interphex Innovations

Supplement

 

Browse other issues »Subscribe to our print issues »

Articles in this Issue

  • Pharmaceutical Instrumentation

    Pharmaceutical instrumentation encompasses a wide variety of products, equipment, and machinery. Each type of instrumentation plays an important role in each unique step of the manufacturing process.
  • An Interview With... Tim Russell, TSI Global Product Manager

    Many facilities choose to install facility monitoring systems to monitor particle counts and other environmental parameters within a manufacturing facility because it makes great business sense. Benefits include waste reduction, improved yield and profits.
  • Biopharm Processing and Packaging

    The growing interest and demand for biopharmaceuticals and biosimilars is pushing the industry to invest in more biopharmaceutical processing and packaging technology and capacity.
  • An Interview With... Alex Kakad, AdvantaPure Product Marketing Manager

    AdvantaPure has a range of product solutions that were designed specifically for low temperature bulk drug storage and transport.
  • An Interview With... Andrew Bulpin, Executive Vice President, Process Solutions, Millipore...

    Biosimiliars, emerging markets, novel therapies and adoption of next generation processing technologies are just a few of the many market dynamics impacting the biopharmaceutical industry. Drug manufacturers are taking a hard look at how to reduce costs, while increasing their flexibility and productivity.
  • An Interview With... Hélène Pora, Vice President Technical Communication & Regulatory Strategy,...

    Single-use technologies are well into the adoption phase, with most of today’s drug manufacturers implementing them in one or more steps of their small and large molecule production processes. In fact, there are many manufacturers implementing single-use process flows wherever possible, but this is not always feasible depending on the age and scale of both the company and the process.
  • An Interview with... Kevin McLean Quality and Technical Director – Americas SGD Pharma Packaging

    We pursue the goal of “think globally and act locally”. Customers absolutely need local, or at least regional, technical support, yet at the same time there are global harmonization goals for customers and at regulatory levels.
  • Contract Manufacturing and Services

    As the global pharmaceutical market continues to evolve, it’s apparent that the use of, and need for contract service and manufacturing providers will continue to expand.
  • Solid Dosage Processing and Packaging

    Solid dosage processing involves a variety of technologies in order to take an active pharmaceutical ingredient (API) and potentially combine it with excipients to create a finished dosage, such as a capsule or tablet. Once that solid dosage is in its final form, it must be properly packaged for distribution. Generally speaking, oral solid dosage forms are the most commonly used pharmaceuticals to treat diseases and conditions.
  • Raw Materials, Excipients and APIs

    Pharmaceutical raw materials include both active pharmaceutical ingredients (APIs) and inactive ingredients or excipients. APIs are bulk drugs that are pharmaceutically active and generate a desired pharmacological effect, whereas, excipients are pharmacologically inactive substances that are generally used as a carrier of the API in the drug.
  • <<
  • >>